The U.S. is slashing funding for scientific research, after decades of deep investment. Here’s some of what those taxpayer dollars created.
Category: Premature Babies
-
He Fought Claims of Harm From Infant Formula. Now He Regulates It.
Kyle Diamantas, a former corporate lawyer, is the new director for the F.D.A. food division, which oversees infant formula. He defended a top maker in cases claiming the company had not warned of potential risks to very low-weight babies.
-
Preterm Birth Drug Withdrawn After 12 Years
The New York Times – Business:The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.
-
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The New York Times – Business:The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.